Barbra McDonagh Blair, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Gram-Positive Bacterial Infections | 1 | 2024 | 341 | 0.780 |
Why?
|
Communicable Diseases | 2 | 2018 | 880 | 0.640 |
Why?
|
Organ Transplantation | 2 | 2019 | 1139 | 0.640 |
Why?
|
Bacteremia | 1 | 2024 | 962 | 0.580 |
Why?
|
Travel | 3 | 2020 | 788 | 0.570 |
Why?
|
Legionnaires' Disease | 1 | 2012 | 48 | 0.430 |
Why?
|
Legionella pneumophila | 1 | 2012 | 46 | 0.430 |
Why?
|
Kidney Transplantation | 1 | 2024 | 4251 | 0.330 |
Why?
|
Bacteriuria | 1 | 2023 | 102 | 0.220 |
Why?
|
Panuveitis | 1 | 2021 | 32 | 0.200 |
Why?
|
Toxoplasmosis | 1 | 2021 | 91 | 0.190 |
Why?
|
Toxoplasma | 1 | 2021 | 150 | 0.180 |
Why?
|
Communicable Disease Control | 2 | 2018 | 857 | 0.180 |
Why?
|
Antitoxins | 2 | 2010 | 81 | 0.170 |
Why?
|
Multiple Organ Failure | 1 | 2021 | 390 | 0.170 |
Why?
|
Food Safety | 1 | 2018 | 22 | 0.170 |
Why?
|
Enterotoxins | 2 | 2010 | 368 | 0.160 |
Why?
|
Vaccination | 3 | 2019 | 3278 | 0.150 |
Why?
|
Urinary Tract Infections | 1 | 2023 | 788 | 0.150 |
Why?
|
Preventive Medicine | 1 | 2019 | 264 | 0.150 |
Why?
|
Immunomodulation | 1 | 2020 | 541 | 0.140 |
Why?
|
Immunocompromised Host | 1 | 2021 | 847 | 0.140 |
Why?
|
Postoperative Complications | 1 | 2018 | 15295 | 0.140 |
Why?
|
Shock, Cardiogenic | 1 | 2021 | 688 | 0.140 |
Why?
|
Bacterial Toxins | 3 | 2011 | 931 | 0.130 |
Why?
|
Myocarditis | 1 | 2021 | 771 | 0.120 |
Why?
|
Infection Control | 1 | 2020 | 966 | 0.110 |
Why?
|
Dysarthria | 1 | 2012 | 57 | 0.110 |
Why?
|
Bone Marrow Transplantation | 1 | 2020 | 2765 | 0.110 |
Why?
|
Hepatitis C Antibodies | 1 | 2012 | 145 | 0.110 |
Why?
|
Postoperative Care | 1 | 2019 | 1486 | 0.100 |
Why?
|
Vaccines | 1 | 2020 | 822 | 0.100 |
Why?
|
Enterocolitis, Pseudomembranous | 2 | 2010 | 264 | 0.100 |
Why?
|
Urine | 1 | 2012 | 370 | 0.100 |
Why?
|
Viral Core Proteins | 1 | 2011 | 162 | 0.090 |
Why?
|
Confusion | 1 | 2012 | 275 | 0.090 |
Why?
|
Vaccines, Attenuated | 1 | 2011 | 342 | 0.090 |
Why?
|
Antibodies, Monoclonal | 3 | 2012 | 9274 | 0.090 |
Why?
|
Listeria monocytogenes | 1 | 2011 | 250 | 0.080 |
Why?
|
Anti-Bacterial Agents | 2 | 2024 | 7181 | 0.080 |
Why?
|
Hematologic Neoplasms | 1 | 2020 | 1832 | 0.080 |
Why?
|
Liver | 1 | 2024 | 7474 | 0.080 |
Why?
|
Immunity, Mucosal | 1 | 2011 | 490 | 0.080 |
Why?
|
Antigens, Bacterial | 1 | 2012 | 1171 | 0.070 |
Why?
|
Bacterial Proteins | 2 | 2010 | 3848 | 0.070 |
Why?
|
HIV Infections | 1 | 2012 | 16718 | 0.070 |
Why?
|
Case-Control Studies | 1 | 2024 | 21746 | 0.070 |
Why?
|
Radiography, Thoracic | 1 | 2012 | 1265 | 0.070 |
Why?
|
Hepacivirus | 1 | 2012 | 1379 | 0.060 |
Why?
|
Headache | 1 | 2012 | 1226 | 0.060 |
Why?
|
Hepatitis C, Chronic | 1 | 2012 | 1031 | 0.060 |
Why?
|
Antibodies, Bacterial | 1 | 2009 | 1470 | 0.060 |
Why?
|
Influenza Vaccines | 1 | 2011 | 738 | 0.060 |
Why?
|
Clostridium Infections | 1 | 2010 | 548 | 0.060 |
Why?
|
Hemangiosarcoma | 1 | 2005 | 239 | 0.060 |
Why?
|
Risk | 1 | 2015 | 9687 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2020 | 5442 | 0.050 |
Why?
|
Interferon-gamma | 1 | 2011 | 3206 | 0.050 |
Why?
|
Hepatitis C | 1 | 2012 | 1591 | 0.050 |
Why?
|
RNA-Binding Proteins | 1 | 2011 | 1903 | 0.050 |
Why?
|
Heart Neoplasms | 1 | 2005 | 374 | 0.050 |
Why?
|
Humans | 14 | 2024 | 744343 | 0.050 |
Why?
|
Toxoplasmosis, Ocular | 1 | 2021 | 29 | 0.050 |
Why?
|
Genetic Vectors | 1 | 2011 | 3420 | 0.050 |
Why?
|
Urinalysis | 1 | 2023 | 369 | 0.050 |
Why?
|
Risk Factors | 2 | 2024 | 72290 | 0.040 |
Why?
|
Endophthalmitis | 1 | 2021 | 262 | 0.040 |
Why?
|
Adult | 5 | 2024 | 214055 | 0.040 |
Why?
|
Retrospective Studies | 2 | 2024 | 77449 | 0.040 |
Why?
|
HIV-1 | 1 | 2012 | 6939 | 0.030 |
Why?
|
Secondary Prevention | 2 | 2010 | 1530 | 0.030 |
Why?
|
Pan troglodytes | 1 | 2012 | 229 | 0.030 |
Why?
|
Nucleocapsid Proteins | 1 | 2011 | 77 | 0.020 |
Why?
|
Hemolysin Proteins | 1 | 2011 | 113 | 0.020 |
Why?
|
Enzyme-Linked Immunospot Assay | 1 | 2011 | 130 | 0.020 |
Why?
|
Acute Disease | 1 | 2021 | 7149 | 0.020 |
Why?
|
Neutralization Tests | 1 | 2012 | 758 | 0.020 |
Why?
|
Male | 7 | 2023 | 350118 | 0.020 |
Why?
|
Curriculum | 1 | 2023 | 3605 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2021 | 12959 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20129 | 0.020 |
Why?
|
Metronidazole | 1 | 2010 | 217 | 0.020 |
Why?
|
Viral Envelope Proteins | 1 | 2012 | 635 | 0.020 |
Why?
|
Heat-Shock Proteins | 1 | 2011 | 822 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8663 | 0.020 |
Why?
|
Vancomycin | 1 | 2010 | 501 | 0.020 |
Why?
|
Antibody Formation | 1 | 2011 | 1402 | 0.020 |
Why?
|
Double-Blind Method | 2 | 2010 | 12026 | 0.020 |
Why?
|
Brain | 1 | 2012 | 26385 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2011 | 1375 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2012 | 35421 | 0.020 |
Why?
|
Placebos | 1 | 2009 | 1676 | 0.020 |
Why?
|
Databases, Factual | 1 | 2020 | 7729 | 0.020 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2005 | 364 | 0.010 |
Why?
|
Mass Screening | 1 | 2020 | 5255 | 0.010 |
Why?
|
RNA, Viral | 1 | 2012 | 2902 | 0.010 |
Why?
|
Viral Load | 1 | 2012 | 3299 | 0.010 |
Why?
|
Ascites | 1 | 2005 | 344 | 0.010 |
Why?
|
Pericardial Effusion | 1 | 2005 | 247 | 0.010 |
Why?
|
Diarrhea | 1 | 2010 | 1348 | 0.010 |
Why?
|
Vomiting | 1 | 2005 | 636 | 0.010 |
Why?
|
Antibodies | 1 | 2010 | 2460 | 0.010 |
Why?
|
Liver Transplantation | 1 | 2012 | 2119 | 0.010 |
Why?
|
Edema | 1 | 2005 | 789 | 0.010 |
Why?
|
Pericardium | 1 | 2005 | 667 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2005 | 1850 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2020 | 57776 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2020 | 7659 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2012 | 13815 | 0.010 |
Why?
|
Middle Aged | 3 | 2021 | 213383 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2010 | 6489 | 0.010 |
Why?
|
Young Adult | 2 | 2020 | 56430 | 0.010 |
Why?
|
Heart Atria | 1 | 2005 | 1357 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2011 | 4560 | 0.010 |
Why?
|
Echocardiography, Transesophageal | 1 | 2005 | 1133 | 0.010 |
Why?
|
Cell Line | 1 | 2012 | 15997 | 0.010 |
Why?
|
Infant | 1 | 2020 | 35136 | 0.010 |
Why?
|
Dyspnea | 1 | 2005 | 1303 | 0.010 |
Why?
|
Aged | 3 | 2020 | 163280 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 41006 | 0.010 |
Why?
|
Radiography | 1 | 2005 | 7023 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2012 | 18029 | 0.010 |
Why?
|
Pulmonary Embolism | 1 | 2005 | 2376 | 0.010 |
Why?
|
Child | 1 | 2020 | 77709 | 0.010 |
Why?
|
Adolescent | 1 | 2020 | 85781 | 0.010 |
Why?
|
Female | 3 | 2020 | 380194 | 0.010 |
Why?
|
Animals | 2 | 2012 | 168757 | 0.010 |
Why?
|
Mutation | 1 | 2012 | 29786 | 0.000 |
Why?
|
Lung | 1 | 2005 | 9856 | 0.000 |
Why?
|
Prospective Studies | 1 | 2009 | 53288 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2011 | 63114 | 0.000 |
Why?
|
Mice | 1 | 2011 | 81183 | 0.000 |
Why?
|